Diversity and complexity in DNA recognition by transcription factors G Badis, MF Berger, AA Philippakis, S Talukder, AR Gehrke, SA Jaeger, ... Science 324 (5935), 1720-1723, 2009 | 1180 | 2009 |
STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer D Iliopoulos, SA Jaeger, HA Hirsch, ML Bulyk, K Struhl Molecular cell 39 (4), 493-506, 2010 | 1017 | 2010 |
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication RC Kessler, LA Adler, R Barkley, J Biederman, CK Conners, SV Faraone, ... Biological psychiatry 57 (11), 1442-1451, 2005 | 861 | 2005 |
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ... Cancer discovery 5 (8), 850-859, 2015 | 797 | 2015 |
Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences MF Berger, G Badis, AR Gehrke, S Talukder, AA Philippakis, ... Cell 133 (7), 1266-1276, 2008 | 729 | 2008 |
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer RB Corcoran, T André, CE Atreya, JHM Schellens, T Yoshino, JC Bendell, ... Cancer discovery 8 (4), 428-443, 2018 | 597 | 2018 |
An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis M Hatziapostolou, C Polytarchou, E Aggelidou, A Drakaki, GA Poultsides, ... Cell 147 (6), 1233-1247, 2011 | 562 | 2011 |
Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication T Roth, S Jaeger, R Jin, A Kalsekar, PE Stang, RC Kessler Biological psychiatry 60 (12), 1364-1371, 2006 | 507 | 2006 |
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication RC Kessler, EF Coccaro, M Fava, S Jaeger, R Jin, E Walters Archives of general psychiatry 63 (6), 669-678, 2006 | 448 | 2006 |
A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases HA Hirsch, D Iliopoulos, A Joshi, Y Zhang, SA Jaeger, M Bulyk, ... Cancer cell 17 (4), 348-361, 2010 | 399 | 2010 |
A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer RMJM Van Geel, J Tabernero, E Elez, JC Bendell, A Spreafico, M Schuler, ... Cancer discovery 7 (6), 610-619, 2017 | 249 | 2017 |
Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes L Zhang, KD MacIsaac, T Zhou, PY Huang, C Xin, JR Dobson, K Yu, ... Molecular Cancer Research 15 (12), 1722-1732, 2017 | 161 | 2017 |
Neurotensin signaling activates microRNAs-21 and-155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors K Bakirtzi, M Hatziapostolou, I Karagiannides, C Polytarchou, S Jaeger, ... Gastroenterology 141 (5), 1749-1761. e1, 2011 | 149 | 2011 |
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer Discov. 2015; 5: 850–859 … GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ... Go to original source... Go to PubMed, 2015 | 122 | 2015 |
Systematic identification of mammalian regulatory motifs' target genes and functions JB Warner, AA Philippakis, SA Jaeger, FS He, J Lin, ML Bulyk Nature methods 5 (4), 347-353, 2008 | 115 | 2008 |
Genomic analysis and 3-y efficacy and safety update of COMBI-d: A phase 3 study of dabrafenib (D)+ trametinib (T) vs D monotherapy in patients (pts) with unresectable or … K Flaherty, MA Davies, JJ Grob, GV Long, PD Nathan, A Ribas, C Robert, ... Journal of Clinical Oncology 34 (15_suppl), 9502-9502, 2016 | 89 | 2016 |
Smoking and suicidal behaviors in the National Comorbidity Survey: Replication RC Kessler, PA Berglund, G Borges, RC Castilla-Puentes, MD Glantz, ... The Journal of nervous and mental disease 195 (5), 369-377, 2007 | 85 | 2007 |
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth J Chen, F Chung, G Yang, M Pu, H Gao, W Jiang, H Yin, V Capka, ... Oncotarget 4 (12), 2502, 2013 | 84 | 2013 |
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition Y Chen, J Chen, A Loo, S Jaeger, L Bagdasarian, J Yu, F Chung, J Korn, ... Oncotarget 4 (6), 816, 2013 | 73 | 2013 |
Combined BRAF, EGFR, and MEK inhibition in patients with BRAF (V600E)-mutant colorectal cancer. Cancer Discov. 2018; 8: 428–443. doi: 10.1158/2159-8290 RB Corcoran, T André, CE Atreya, JHM Schellens, T Yoshino, JC Bendell, ... CD-17-1226.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 55 | |